Применение прегабалина при генерализованном тревожном расстройстве
Сторожакова Янина Абрамовна · Социальная и клиническая психиатрия · 2014
The article presents a detailed description and analysis of two foreign clinical trials focusing on anxiolytic efficacy and safety of pregabalin in patients with generalized anxiety disorder (GAD). Both clinical trials were designed as randomized, double-blind, placebo-controlled, fi xed-dose, activecomparator study of pregabalin in order to define its therapeutic properties in comparison with benzodiazepines along with its better tolerability and absence of withdrawal symptoms. The trials support the hypothesis that pregabalin is effective and safe in short-term therapy for GAD.
Cited by 0 works.